A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia
Status:
Completed
Trial end date:
2015-05-06
Target enrollment:
Participant gender:
Summary
A dose-escalation study to identify the dose-limiting toxicity (DLT) and maximum tolerated
dose (MTD), defined as the highest dose that can safely be given to a participant and
establish the safest dose based on the highest tolerated dose for clinical testing.